Announced Fri, 19 Jun · 11:31 IST
Promoter encumbrance of 57.49% shares released after notes repayment
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹414.10
prior close
₹405.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.1+0.0-2.4+10.4+11.1+10.3+8.7+8.9+8.3+8.5——
Up moveDown movePending
AI summary
Encumbrance over 21,99,30,170 shares (57.49 percent of share capital) of Cohance Lifesciences held by promoters Berhyanda (33.34 percent) and Jusmiral Holdings (24.15 percent) has been fully released effective June 16, 2026. The release followed full repayment of notes issued under a May 2024 Notes Purchase Agreement. The encumbrance was indirect, created via covenants and offshore pledge agreements on the promoter holding entities, not directly on company shares.
Likely market impact
Positive for shareholders: promoter shares freed from encumbrance, reducing pledge risk and signalling improved financial flexibility after debt repayment.